Janux Therapeutics, Inc. (JANX)
14.52
+0.11
(+0.76%)
USD |
NASDAQ |
May 22, 16:00
14.52
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics EPS Diluted (Quarterly) : -0.3888 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Gilead Sciences, Inc. | 1.612 |
| ADMA Biologics, Inc. | 0.1889 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.36M |
| Revenue (Quarterly) | 3.733M |
| Total Expenses (Quarterly) | 28.09M |
| Enterprise Value | -49.32M |
| Gross Profit Margin (Quarterly) | 87.44% |
| Profit Margin (Quarterly) | -652.6% |
| Earnings Yield | -12.68% |
| Normalized Earnings Yield | -12.68 |